Fred Alger Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-30,000
| Closed | -$746K | – | 582 |
|
|
2018
Q3 | $746K | Hold |
30,000
| – | – | ﹤0.01% | 340 |
|
|
2018
Q2 | $824K | Sell |
30,000
-13,915
| -32% | -$382K | ﹤0.01% | 341 |
|
|
2018
Q1 | $1.35M | Buy |
43,915
+18,915
| +76% | +$583K | 0.01% | 315 |
|
|
2017
Q4 | $894K | Buy |
+25,000
| New | +$894K | ﹤0.01% | 342 |
|
|
2016
Q2 | – | Sell |
-84,288
| Closed | -$1.47M | – | 571 |
|
|
2016
Q1 | $1.47M | Sell |
84,288
-110,528
| -57% | -$1.93M | 0.01% | 342 |
|
|
2015
Q4 | $6.66M | Buy |
+194,816
| New | +$6.66M | 0.03% | 221 |
|